Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BIO2 Sweden AB
AB
Active
Org 5591684963
Skåpesund 15
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2018
1-4 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 2,1M
+558% vs 2023
EBITDA margin
38.3%
+806% vs 2023
Equity ratio
43.4%
Financial strength
Net profit 2024
SEK 467K
+544% vs 2023
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
1M
+100%
2024
Key figures
Annual report 2024
Revenue
SEK 2,1M
+558%
EBITDA
SEK 799K
+806%
Net profit
SEK 467K
+544%
Total assets
SEK 1,3M
+380%
Equity
SEK 556K
+526%
Employees
—
—
Company information
Legal name
BIO2 Sweden AB
Org number
5591684963
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
21 augusti 2018
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Tillverkare av tandimplantat och implantatkomponenter Tillverkning av tandproteser Partihandel med medicinsk utrustning och apoteksvaror
Contact
Address
Skåpesund 15
Email
escobar_bach@msn.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Göteborg
All Sweden companies
Revenue
SEK millions
0M
1M
1M
2M
2M
0M
2020
0M
2021
0M
2022
0M
2023
2M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
1M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
317
2 085
Staff expenses
—
—
—
−166
−1 066
EBITDA
−10
−6
8
88
799
Depreciation & amort.
−0
−0
−0
—
—
EBIT
−10
−6
8
88
799
Net financials
—
—
—
−0
−0
Profit before tax
−10
−6
8
88
593
Tax
−0
−0
−0
−16
−127
Net profit
−10
−6
8
72
467
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
44
38
48
267
1 279
Equity
50
56
48
89
556
Long-term debt
0
0
0
—
—
Short-term debt
6
18
0
178
518
Total debt
6
18
—
178
518
Financial ratios
5-year trend
EBITDA margin
38.3%
This company
15.8%
Market median
+142% vs market
2020
2024
Equity ratio
43.4%
This company
38.2%
Market median
+14% vs market
2020
2024
Return on equity
84.0%
This company
18.4%
Market median
+357% vs market
2020
2024
Net profit margin
22.4%
This company
8.1%
Market median
+177% vs market
2020
2024
Asset turnover
1.63×
This company
1.12×
Market median
+46% vs market
2020
2024
Debt / equity
1.30×
This company
0.62×
Market median
-110% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
MB
Mikael Bach
Board of Directors
2019
AB
Afrouz Behboudi Bach
Deputy Board Member
2024
Former (1)
AM
Aina Margrethe Larsson
Deputy Board Member
2019 – 2024
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of BIO2 Sweden AB also hold positions in
0
other companies.
Person
Role here
Other companies
Mikael Bach
Board of Directors
0 companies
Aina Margrethe Larsson
Deputy Board Member
0 companies
Afrouz Behboudi Bach
Deputy Board Member
0 companies